App-Quantinova.ai

Effect of liraglutide 1.8 mg in patients with non-controlled type 2 diabetes mellitus at an Endocrinology Clinic: LIED-2 study

Alvaro A Herrera - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Liraglutide

Fungal sinusitis caused by Aspergillus in a patient with type 1 diabetes

Nurettin Erben - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hematological malignancies

Itraconazole

Once-weekly exenatide in a real-world clinical setting: clinical outcomes and analysis of potential predictors of response

Jose Carlos Fernandez-Garcia - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Exenatide

Diabetic kidney disease and its association with macrovascular disease in diabetic patients

Gonzalo Allo Miguel - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left ventricular hypertrophy

N/A

Intensive glycemic control fails to improve indices of vascular dysfunction in patients with type 2 diabetes; results at 612 months follow-up

Sofia Antoniou - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Hypoglycaemia due to drug interaction with clarithromycin

Catarina Ivo - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Metformin/vildagliptin

Associations of serum magnesium levels with diabetes and diabetic complications

Aysel Gurkan Tocoglu - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic retinopathy

N/A

Scleredema in a patient with long-standing type 2 diabetes mellitus

Senay Arikan Durmaz - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Metformin Hydrochloride

SUMO4 163G>A variation is associated with kidney disease in type 2 diabetes in Indian population

Nisha Sinha - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic nephropathy

methionine

Real-time sonoelastography and ultrasound evaluation of Achilles tendon of diabetic patients

Ilkay Idilman - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Peripheral artery disease

N/A

Effect of gemigliptin switching from pioglitazone with metformin in type 2 diabetes

Donghyun Shin - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Pioglitazone

The use of insulin pump therapy in the paediatric age group

Angelica Solntsava - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

The diabetic hand: a forgotten complication?

Emine Duygu Ersozlu Bozkirli - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Study of irisin hormone level in type 2 diabetic patients and patients with diabetic nephropathy

Manal Abushady - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Chronic kidney disease

N/A

Distribution of fat mass in young type 1 diabetic patients

Alla Shepelkevich - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Assessment of the myelin damage degree in patients with and without diabetic neuropathy

Iryna Kostitska - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic neuropathy

N/A

New-onset diabetes after renal transplantation (NODAT) and nodular glomerulosclerosis of the renal allograft

Carla Baptista - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic renal allograft dysfunction

Prednisone

Association of SNPs in the intergenic region of OCT2 and OCT3 with short-term efficiency of metformin monotherapy in the type 2 diabetes patients

Linda Zaharenko - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Metformin Hydrochloride

Bone mineral density in patients with type 1 diabetes mellitus by DEXA and QCT

Spyros Karamagiolis - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Is early measurement of HbA1c useful for the prediction of treatment response in type 2 diabetes?

Besmir Nreu - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Metformin Hydrochloride

Filters

4759 Abstracts